220 related articles for article (PubMed ID: 38161496)
1. Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
Wang H; Chen J; Zhang X; Sheng X; Chang XY; Chen J; Chen MS; Dong H; Duan GJ; Hu HP; Huang ZY; Jia WD; Jiang XQ; Kuang D; Li SS; Li ZS; Lu CL; Qin SK; Qiu XS; Qu LJ; Shao CK; Shen F; Shi GM; Shi SS; Shi YJ; Sun HC; Teng XD; Wang B; Wang ZB; Wen TF; Yang JM; Yang QQ; Ye SL; Yin HF; Yuan ZG; Yun JP; Zang FL; Zhang HQ; Zhang LH; Zhao JM; Zhou J; Zhou WX; Fan J; Chen XP; Lau WY; Ji Y; Cong WM;
J Clin Transl Hepatol; 2023 Dec; 11(7):1553-1564. PubMed ID: 38161496
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.
Zen Y
Hum Pathol; 2023 Feb; 132():197-207. PubMed ID: 35697170
[TBL] [Abstract][Full Text] [Related]
3. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
Makino K; Ishii T; Takeda H; Saito Y; Fujiwara Y; Fujimoto M; Ito T; Wakama S; Kumagai K; Munekage F; Horie H; Tomofuji K; Oshima Y; Uebayashi EY; Kawai T; Ogiso S; Fukumitsu K; Takai A; Seno H; Hatano E
J Pathol; 2024 May; 263(1):32-46. PubMed ID: 38362598
[TBL] [Abstract][Full Text] [Related]
4. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review.
Akita M; Yanagimoto H; Tsugawa D; Zen Y; Fukumoto T
Surg Today; 2024 Apr; ():. PubMed ID: 38563999
[TBL] [Abstract][Full Text] [Related]
5. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.
Komuta M
Clin Mol Hepatol; 2022 Jul; 28(3):396-407. PubMed ID: 35032970
[TBL] [Abstract][Full Text] [Related]
7. Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.
Nguyen Canh H; Takahashi K; Yamamura M; Li Z; Sato Y; Yoshimura K; Kozaka K; Tanaka M; Nakanuma Y; Harada K
Histopathology; 2021 Nov; 79(5):731-750. PubMed ID: 34018212
[TBL] [Abstract][Full Text] [Related]
8. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma.
Kinzler MN; Schulze F; Jeroch J; Schmitt C; Ebner S; Gretser S; Bein J; Finkelmeier F; Trojan J; Zeuzem S; Schnitzbauer AA; Demes MC; Reis H; Wild PJ; Walter D
Histopathology; 2024 May; 84(6):1061-1067. PubMed ID: 38409827
[TBL] [Abstract][Full Text] [Related]
10. Histopathological evidence of intrahepatic cholangiocarcinoma occurring in ductal plate malformation: A clinicopathologic study of 5 cases.
Wang Q; Xu Y; Wang SM; Hu AY; Pan YC; Zhang SH
Ann Diagn Pathol; 2021 Dec; 55():151828. PubMed ID: 34571341
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomics Reveals Down-Regulated Glycolysis/Gluconeogenesis in the Large-Duct Type Intrahepatic Cholangiocarcinoma.
Guo Y; Li Q; Ren W; Wu H; Wang C; Li X; Xue B; Qiu Y; Zhang J; Chen J; Fang L
J Proteome Res; 2022 Oct; 21(10):2504-2514. PubMed ID: 36066509
[TBL] [Abstract][Full Text] [Related]
12. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
[TBL] [Abstract][Full Text] [Related]
13. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
[TBL] [Abstract][Full Text] [Related]
14. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.
Mancinelli R; Cutone A; Rosa L; Lepanto MS; Onori P; Pannarale L; Franchitto A; Gaudio E; Valenti P
Eur J Histochem; 2020 Oct; 64(4):. PubMed ID: 33131269
[TBL] [Abstract][Full Text] [Related]
15. Challenges in Diagnosing and Reporting Cholangiocarcinoma.
El Jabbour T; Molnar A; Lagana SM
Surg Pathol Clin; 2023 Sep; 16(3):599-608. PubMed ID: 37536891
[TBL] [Abstract][Full Text] [Related]
16. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.
Chung T; Rhee H; Shim HS; Yoo JE; Choi GH; Kim H; Park YN
Gut Liver; 2022 Jul; 16(4):613-624. PubMed ID: 34810298
[TBL] [Abstract][Full Text] [Related]
17. Distinct sulfated glycans expressed in intrahepatic cholangiocarcinoma: a potential target for new therapy.
Hoshino H; Kobayashi M
Immunotherapy; 2023 May; 15(7):503-516. PubMed ID: 36789618
[TBL] [Abstract][Full Text] [Related]
18. Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study.
Vasuri F; Deserti M; Corradini AG; Tavolari S; Relli V; Palloni A; Frega G; Curti S; Mattioli S; Cescon M; D'Errico A; Brandi G
Sci Rep; 2023 Feb; 13(1):2580. PubMed ID: 36781903
[TBL] [Abstract][Full Text] [Related]
19. Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.
Chung T; Park YN
Front Med (Lausanne); 2022; 9():857140. PubMed ID: 35433771
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of intrahepatic cholangiocarcinoma.
Haga H; Patel T
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):114-23. PubMed ID: 25267595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]